Viveta Cream

Introduction

Viveta is a topical medication that contains two active ingredients: Lidocaine and Tetracaine. It is commonly used to provide temporary relief from pain and discomfort associated with various skin conditions.

Uses

Viveta is prescribed for the temporary relief of pain and discomfort caused by minor skin irritations, such as sunburn, insect bites, and rashes. It can also be used to numb the skin before certain medical procedures, such as injections or minor surgeries.

Dosage and Administration

Before applying Viveta, clean and dry the affected area. Gently apply a thin layer of the cream to cover the entire area. The cream should not be rubbed into the skin. The recommended dosage and frequency of application may vary depending on the severity of the condition and the specific instructions provided by your healthcare professional. Follow their guidance and not exceed the recommended dosage.

Mechanism of Action

Lidocaine and Tetracaine, the active ingredients in Viveta, work by temporarily numbing the skin and reducing pain signals. Lidocaine blocks the transmission of pain signals from the nerves to the brain, while Tetracaine works by inhibiting the nerve endings’ ability to transmit pain signals. This combined action helps to provide temporary relief from pain and discomfort.

Side Effects

Common side effects may include mild skin irritation, redness, or itching at the application site. These side effects are usually mild and temporary.

However, if you experience any severe or persistent side effects, such as severe skin irritation, rash, swelling, or difficulty breathing, seek medical attention immediately. These may be signs of an allergic reaction or other serious adverse effects.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including over-the-counter products and herbal supplements. Certain medications may interact with Viveta, potentially affecting its effectiveness or increasing the risk of side effects. It is particularly important to avoid using other topical medications or creams in the same area without consulting your healthcare professional.

Precautions

Before using Viveta, inform your healthcare professional if you have any known allergies to Lidocaine, Tetracaine, or any other local anesthetics. Additionally, let them know if you have any underlying medical conditions or if you are pregnant or breastfeeding.

Viveta is for external use only and should not be applied to broken or damaged skin. Avoid contact with eyes, mouth, or other mucous membranes. If accidental contact occurs, rinse thoroughly with water.

Storage

Viveta should be stored at room temperature, away from direct sunlight and moisture. Keep the cream out of the reach of children and pets. Do not use the cream if it has passed the expiration date printed on the packaging.

Patient Tips

• Wash your hands before and after applying the cream.
• Avoid covering the treated area with airtight dressings or bandages unless specifically instructed by your healthcare professional.
• If you are using Viveta to numb the skin before a medical procedure, follow the instructions provided by your healthcare professional.
• If your symptoms worsen or do not improve after a few days of using the cream, consult your healthcare professional for further evaluation and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Lidocaine skin cream: a medicine to numb the skin (NHS UK) [Accessed 9 Jun. 2024] (online) Available at:
• Anbesol Adult Strength Gel (Health Professionals SmPC) Available at:
• Lidocaine injection (Drugs.com) [Accessed 5 Jun. 2024] (online) Available at:
• aspercreme (lidocaine) 4 % topical (OTC) [Accessed 25 Jun. 2024] (online) Available at:
• Lidocaine Transdermal Patch (MedlinePlus) [Accessed 7 Jun. 2024] (online) Available at:
• Walker IA, Slovis CM. Lidocaine in the treatment of status epilepticus. Acad Emerg Med. 1997 Sep;4(9):918-22. doi: 10.1111/j.1553-2712.1997.tb03820.x. [Accessed 10 Jun. 2024] Available at: